Microsoft word - tpa quick ref guide 2009.doc
CLINICAL OPHTHALMIC
THERAPEUTIC PHARMACEUTICAL
AGENTS (TPA) QUICK REFERENCE
NSAO Practice Innovations Committee Chairperson
Ocular Allergies
Acute Allergy Therapy:
Brand Name
Generic Name
Manufacturer Bottle
phosphate 0.51%, naphazoline hydrochloride 0.051%
Chronic Allergy Therapy:
Brand Name
Generic Name
Manufacturer Bottle
Size Dosing
Antimicrobial Agents
Fluoroquinolones:
Brand
Manufacturer Preparation Pediatric
Bottle/Tube
Aminoglycosides:
Brand
Manufacturer Preparation Pediatric
Bottle/Tube
Polymyxin B Combinations:
Brand
Manufacturer Preparation Pediatric
Bottle/Tube
Fusidic Acid:
Brand Name
Manufacturer Preparation Pediatric
Bottle/Tube
Erythromycin:
Brand Name
Manufacturer Preparation Pediatric Bottle/Tube
Over-the-counter Anti-Infectives:
Product Name
Antibiotic
Preservative
Herpes Infections:
Brand Name
Generic Name
Manufacturer
Preparation
Bottle/Tube
Anti-inflammatory Agents
Corticosteroid/Antibiotic Combination Drugs:
Brand
Manufacturer Steroid
Antibiotic
Preparation Bottle/Tube
Name
Blephamide Allergan
Maximum Strength Topical Corticosteroid Drugs:
Brand Name
Generic Name
Manufacturer
Preparation
Bottle/Tube
Moderate Strength Topical Corticosteroid Drugs:
Brand Name
Generic Name
Manufacturer
Preparation
Bottle/Tube
To Taper Steroids: An important reason for tapering steroids is the rebound effect of local inflammation.
Abruptly discontinuing topical steroids may allow the suppressed inflammation to bounce back. A good
rule of thumb: taper dosage frequency by about a 50% reduction once inflammation is under control.
Example: Q1H for two days, Q2H for two days, QID for four days, BID for four days.
Non-steroidal Anti-inflammatory Drugs:
Brand Name
Generic Name
Manufacturer
Preparation
Bottle/Tube
Topical Glaucoma Drugs
Beta Blockers:
Brand Name
Generic Name
Manufacturer Concentration Bottle
Prostaglandin Analogs:
Brand Name
Generic Name
Manufacturer Concentration Bottle
Alpha Agonists:
Brand Name
Generic Name
Manufacturer Concentration Bottle
Carbonic Anhydrase Inhibitors:
Brand Name
Generic Name
Manufacturer Concentration Bottle
Combination Glaucoma Medications:
Brand Name
Generic Name
Manufacturer Concentration Bottle
Miscellaneous
Hyperosmolar Agents:
Brand
Manufacturer Preparation Bottle/Tube Dosing
Mydriatics and Cycloplegics:
Generic Name
Trade Name
Concentration
Duration of
Action
Topical Anesthetic Agents:
USP or NF Name
Trade Name
Concentration
Dry Eye Therapy
Temporary Preservative:
Product Name
Preservative
Lubricant
Castor oil + glycerin 1% + polysorbate 80
Chemical Preservative:
Product Name
Preservative
Lubricant
Preservative-Free:
Product Name
Preservative
Lubricant
Gels with Temporary Preservative:
Product Name
Preservative
Lubricant
Gels with Chemical Preservative:
Product Name
Preservative
Lubricant
Preservative-Free Gels:
Product Name
Preservative
Lubricant
Preservative-Free Emulsion:
Product Name
Preservative
Lubricant
Castor Oil + Polysorbate 80 + Glycerin + Carbomer 1342
Preservative-Free Ointments:
Product Name
Preservative
Lubricants
White petrolatum + mineral oil + Lanolin
Ocular Decongestants
Product Name
Decongestant
Antihistamine Other
Preservative
Source: http://portal.opto.ca/media/all-media-for-provincial-portal/nsao/pdfs-docs/tpa-quick-reference-guide-2009.pdf
Use of Tamiflu for children under the age of one Why does the government think that Tamiflu is safe for children under one (1) now? Health Canada has reviewed the available safety data with respect to the use of Tamiflu in children under 1 year old due to the increased incidences of H1N1. It has concluded that the known and potential benefits of Tamiflu outweigh the known and pot